Hours & Directions

Office Hours

Mon, Tues, Thurs & Fri 8-6
Weds 8-5
Sat 9-2

We’re at the corner of 121 & Main St in The Colony, TX.

Colony Vision Center
4709 HWY 121 Suite 122
The Colony, TX 75056

Vision News

  • Alcon Launches AcrySof(R) IQ ReSTOR(R) Toric Intraocular Lens Outside The United States
  • Starting The School Year Right
  • Drug Discovery Tools To Fight Cancer, Blindness To Be Discussed At UB Symposium
  • 'Back-To-School' How To Prevent Sports Related Eye Injuries
  • Carl Zeiss Meditec Is Shaping The Future Of Ophthalmology: Creating What's To Come
  • OptiMedica's Laser Cataract Surgery System To Be Featured In Three Clinical Presentations At ESCRS 2010
  • Dr. Tom Tooma Purchases Interest In All 12 Southern California TLC Laser Eye Centers, Changing Name To NVISION Laser Eye Centers
  • Bausch + Lomb Releases Single-Use Vitreoretinal Asymmetric Peeling Forceps
  • New Data Will Help Predict Vision Loss In Glaucoma
  • Proprietary Zinc/Phytase Formulation Improved Botulinum Toxin A Results
  • ReVision's Fenretinide (RT-101) Reduced Incidence Of Choroidal Neovascularization By More Than 50 Percent In Patients With Geographic Atrophy
  • Microplasmin Meets Primary Endpoint In Second Phase III Trial In VMA, Confirms Positive Findings Of First Trial
  • pSivida Announces Iluvien(R) Receives FDA Priority Review For Treatment Of Diabetic Macular Edema
  • Allergan Receives FDA Approval For LUMIGAN(R) 0.01% As First-Line Therapy Indicated For The Reduction Of Elevated Intraocular Pressure In Glaucoma
  • Improving Ocular Disease Screening By LED Illumination Of The Eye
  • Eyegenix™ Artificial Cornea Achieves Major Advancement Towards Curing Corneal Blindness
  • Diabetic Macular Edema Drug Iluvien Gets FDA Priority Review
  • Optometrists Encourage Eye Test For Children, Ireland
  • 'Toolbox Of MiniPromoters' For Gene Research And Therapy Unvelied By UBC Researchers
  • Revolutionary Way To Treat Eye Cancer May Prevent Blindness
  • More...
    •